Table 4 Meta-regression analysis.
Moderator* | Coefficient | SMD (95% CI) | t | p |
|---|---|---|---|---|
Specific symptoms | ||||
sessions | 0.03 | 0.06 (0.11 to 0.17) | 0.52 | 0.62 |
current | 0.8 | 0.75 (−1.05 to 2.64) | 1.05 | 0.33 |
session duration | −0.05 | 0.08 (−0.24 to 0.14) | −0.64 | 0.54 |
L-DLPFC | −1.12 | 1.03 (−3.65 to 1.41) | −1.08 | 0.32 |
L-SMA | −0.66 | 1.37 (−4.01 to 2.70) | −0.48 | 0.65 |
L-deltoid | −0.32 | 1.49 (−3.96 to 3.33) | −0.21 | 0.84 |
R-OFC | 0.35 | 1.42 (−3.13 to 3.82) | 0.24 | 0.82 |
R-cerebellum | −0.64 | 1.38 (−4.02 to 2.74) | −0.47 | 0.66 |
General anxiety | ||||
sessions | −0.01 | 0.16 (−0.45 to 0.44) | −0.05 | 0.96 |
current | 0.17 | 1.03 (−2.68 to 3.02) | 0.17 | 0.88 |
session duration | 0 | 0.16 (−0.44 to 0.44) | −0.02 | 0.98 |
L-DLPFC | −0.99 | 1.39 (−4.84 to 2.86) | −0.71 | 0.52 |
R-cerebellum | 0.39 | 1.92 (−4.94 to 5.72) | 0.2 | 0.85 |
Follow-up of specific symptoms | ||||
sessions | 0.05 | 0.09 (−0.18 to 0.28) | 0.55 | 0.61 |
current | 0.77 | 0.99 (−1.78 to 3.32) | 0.77 | 0.47 |
session duration | 0.01 | 0.16 (−0.41 to 0.42) | 0.05 | 0.96 |
L-DLPFC | −0.53 | 1.29 (−3.84 to 2.78) | −0.41 | 0.7 |
L-deltoid | −0.92 | 1.82 (5.60 to 3.76) | −0.51 | 0.64 |
R-IFG | 1.21 | 1.91 (−3.70 to 6.12) | 0.63 | 0.56 |
